Prenatal SSRI use is linked to reduced head growth in study

03/5/2012 | Yahoo! · DailyRx.com

Babies born to mothers who took selective serotonin reuptake inhibitors were more likely to have reduced head growth, a Dutch study found. Mothers with untreated depression were more likely to give birth to babies with overall reduced growth. Researchers also found that mothers who used SSRIs had a higher risk of preterm birth compared with mothers without depression. The findings appear in the Archives of General Psychiatry.

View Full Article in:

Yahoo! · DailyRx.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC